ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,009.14
0.10%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. AlloVir Inc (ALVR)

  7. AlloVir Inc (ALVR) Noticias

ALVR

AlloVir (ALVR)

AlloVir Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ALVR
FechaHoraFuenteTítuloSímboloCompañía
17/05/202419:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
13/05/202415:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALVRAlloVir Inc
07/05/202415:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
14/03/202405:10PR Newswire (US)Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:ALVRAlloVir Inc
07/03/202404:45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit - ALVRNASDAQ:ALVRAlloVir Inc
15/02/202415:30Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:ALVRAlloVir Inc
12/02/202415:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
09/02/202404:45PR Newswire (US)Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:ALVRAlloVir Inc
02/02/202404:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of AlloVir, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2024 - (NASDAQ: ALVR)NASDAQ:ALVRAlloVir Inc
09/01/202411:32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALVRAlloVir Inc
09/01/202411:29Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ALVRAlloVir Inc
05/01/202405:14IH Market NewsWall Street Highlights: Google Rejects Union Negotiations, Exxon Mobil Announces $2.5 Billion Accounting Write-Down in CaliforniaNASDAQ:ALVRAlloVir Inc
22/12/202306:00GlobeNewswire Inc.AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell TherapyNASDAQ:ALVRAlloVir Inc
16/11/202306:00Business WireAlloVir to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:ALVRAlloVir Inc
02/11/202306:00Business WireAlloVir Reports Third Quarter 2023 Financial ResultsNASDAQ:ALVRAlloVir Inc
28/08/202306:00Business WireAlloVir to Present at Upcoming Investor ConferencesNASDAQ:ALVRAlloVir Inc
03/08/202306:00Business WireAlloVir Reports Second Quarter 2023 Financial ResultsNASDAQ:ALVRAlloVir Inc
12/07/202306:41IH Market NewsWednesday’s Wall Street Highlights: Nvidia, VMware, Alphabet, Coty, IBM, and moreNASDAQ:ALVRAlloVir Inc
26/06/202315:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALVRAlloVir Inc
22/06/202316:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ALVRAlloVir Inc
21/06/202320:20Business WireAlloVir Announces Pricing of Public Offering of Common StockNASDAQ:ALVRAlloVir Inc
21/06/202316:01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ALVRAlloVir Inc
21/06/202315:18Business WireAlloVir Announces Proposed Public Offering of Common StockNASDAQ:ALVRAlloVir Inc
13/06/202316:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALVRAlloVir Inc
09/06/202315:22Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ALVRAlloVir Inc
05/06/202306:00Business WireAlloVir Presents Positive Final Results From A Phase 2 Randomized, Placebo-Controlled Trial Evaluating Posoleucel Treatment of BK Infection in Kidney Transplant Recipients at the American Transplant Congress (ATC 2023)NASDAQ:ALVRAlloVir Inc
16/05/202306:00Business WireAlloVir Announces Appointment of Cintia Piccina, PharmD, MBA, as Chief Commercial OfficerNASDAQ:ALVRAlloVir Inc
04/05/202315:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ALVRAlloVir Inc
04/05/202306:00Business WireAlloVir Reports First Quarter 2023 Financial ResultsNASDAQ:ALVRAlloVir Inc
01/05/202315:12Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ALVRAlloVir Inc
 Showing the most relevant articles for your search:NASDAQ:ALVR

Su Consulta Reciente

BIT
UB03TQ
UniCredit Bank
COIN
TNCEUR
TNC Group Token
ASX
ENN
Elanor Investors
NYSE
CIV-CL
USOTC
NPPRF
Nippon Ceramic (PK)
COIN
MARKSUSD
Bitmark
BIT
UC00BG
Unicredit Bank
TSXV
RSN.H
EU
1847T
1847T
NASDAQ
UBPSU
JetPay Corporation
COIN
SHRMUSD
NASDAQ
VNTXX
Mtb New York Tax Free Money Mark
LQID
BERRYUSDT
Berry
LSE
56HR
Nordic 24
LSE
51PE
Investec Bnk 24
CSE
CNTR
CENTR Brands
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados